Glimizone Plus 1000mg/500mg/15mg Tablet SR
Marketer
Carezone Healthcare
Salt Composition
Glimepiride (1000mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimizone Plus 1000mg/500mg/15mg Tablet SR
Glimizone Plus 1000mg/500mg/15mg Extended-Release Tablets combine medications to manage blood glucose. This formulation, used alongside diet and exercise, improves glycemic control in adults with type 2 diabetes. It enhances insulin effectiveness, reducing blood sugar. Dosage and duration for Glimizone Plus should strictly follow your physician's instructions. Administer with food to minimize gastrointestinal discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose; never double the dose. Overdosing can cause hypoglycemia (low blood sugar). Concurrent use with other antidiabetic agents, alcohol, or skipped meals elevates hypoglycemia risk; regular blood glucose monitoring is crucial. Common adverse effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to initiating therapy, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Renal function tests will be conducted before treatment begins. Limit alcohol consumption to mitigate potential side effects.
Uses of Glimizone Plus 1000mg/500mg/15mg Tablet SR
Managing Type 2 Diabetes
Major Benefits of Glimizone Plus 1000mg/500mg/15mg Tablet SR:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the Glimizone Plus 1000mg/500mg/15mg Tablet SR whole; avoid chewing, crushing, or fracturing. Consume with food.
Common Side effects of Glimizone Plus 1000mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimizone Plus 1000mg/500mg/15mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or fracturing it. Consume Glimizone Plus 1000mg/500mg/15mg Extended-Release tablets with food.
How Glimizone Plus 1000mg/500mg/15mg Tablet SR works:
Glimizone Plus, a sustained-release tablet containing 1000mg metformin, 500mg glimepiride, and 15mg pioglitazone, combines three distinct antidiabetic agents. This triple therapy offers enhanced blood glucose management when monotherapy or dual therapy proves inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, reducing blood glucose levels. Metformin, a biguanide, acts through multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further enhances insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Glimizone Plus 1000mg/500mg/15mg Tablet SR is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release Glimizone Plus 1000mg/500mg/15mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against these risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Glimizone Plus tablets (1000mg/500mg/15mg) are likely unsafe for breastfeeding mothers. Available evidence from human studies indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Exercise caution when administering Glimizone Plus 1000mg/500mg/15mg SR tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. The use of Glimizone Plus 1000mg/500mg/15mg SR tablets is contraindicated in patients exhibiting severe kidney disease. Close monitoring of kidney function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimizone Plus 1000mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician. The use of Glimizone Plus 1000mg/500mg/15mg SR tablets is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Glimizone Plus 1000mg/500mg/15mg Tablet SR :
Should you forget a dose of Glimizone Plus 1000mg/500mg/15mg Extended-Release Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimizone Plus 1000mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently